A glucose-blue light AND gate-controlled chemi-optogenetic cell-implanted therapy for treating type-1 diabetes in mice

Overview of attention for article published in Frontiers in Bioengineering and Biotechnology, February 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (60th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,159 followers.

RT @FrontBioeng: New Research: A glucose-blue light AND gate-controlled chemi-optogenetic cell-implanted therapy for treating type-1 diabet…

New Research: A glucose-blue light AND gate-controlled chemi-optogenetic cell-implanted therapy for treating type-1 diabetes in mice https://t.co/7aJZUUfH1s #bioengineering #biotech

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.